N

Neurocrine Biosciences

Develops and markets neurology-focused therapies

Global Head, Medical Drug Safety & Pharmacovigilance

Biology & BiotechConfirmed live in the last 24 hours
Full-timeSan Diego, CA, USAIn-person

About the Job

Requirements

  • Industry-leading expertise in global pharmacovigilance, safety surveillance, signal detection and management, benefit-risk assessment, and risk management.
  • Deep understanding of drug development and the role of medical safety from clinical development through approval and post-marketing.
  • Strong knowledge of international regulatory requirements, particularly FDA and EU/EEA regulations, and pre- and post-marketing drug safety standards.
  • Proficiency with safety databases and safety coding dictionaries such as MedDRA and WHODRUG.
  • Exceptional analytical thinking and advanced medical judgment.
  • Demonstrated ability to provide strategy, vision, and direction on issues with potential company-wide impact.
  • Exceptional influencing, communication, presentation, and decision-making capabilities.
  • Strong leadership capabilities with demonstrated success leading through influence across multidisciplinary teams.
  • Ability to manage multiple complex programs and priorities with a high degree of accountability, accuracy, and effectiveness.
  • M.D. degree, accredited residency in a relevant clinical specialty such as Internal Medicine, Family Practice, or Neurology, Board certification, and clinical/industry experience.
  • 6–10+ years of pharmacovigilance experience in a pharmaceutical or biotechnology company, including leadership in signal management, clinical development, medical review of safety reports, and filings and responses to regulatory safety inquiries.

Responsibilities

  • Partner with the Vice President, Drug Safety to establish and advance medical safety strategy and priorities across the investigational and marketed portfolio.
  • Provide senior medical leadership across the pipeline, identifying portfolio-level safety themes, risks, opportunities, and implications.
  • Integrate safety and benefit-risk considerations into clinical development, regulatory, labeling, and portfolio strategy.
  • Serve as a senior escalation point and thought partner on complex or high-impact safety matters.
  • Anticipate emerging safety issues and translate complex clinical and safety data into clear recommendations for senior decision-makers.
  • Build partnerships with senior and executive leaders across Clinical Development, Regulatory Affairs, Clinical Operations, R&D, and other functions.
  • Represent Drug Safety in senior R&D leadership, governance, and decision-making forums, and represent the Vice President, Drug Safety when appropriate.
  • Contribute to senior governance and Management Committee discussions and preparation on safety, benefit-risk, and development strategy.
  • Support safety strategy and assessments for Board and other senior governance discussions.
  • Prepare clear, decision-oriented narratives from complex safety information for executive, regulatory, governance, and Board-level audiences.
  • Guide integrated safety surveillance, signal detection and management, benefit-risk assessment, and risk management across development and marketed products.
  • Support evaluation of individual and aggregate safety information to identify, investigate, and interpret potential safety signals.
  • Provide senior medical and strategic leadership in interactions with global regulatory authorities on complex safety and pharmacovigilance matters.
  • Translate emerging safety information into appropriate clinical development, regulatory, labeling, and risk-management actions.
  • Lead, develop, and inspire a high-performing team of safety physicians while shaping the Drug Safety organization's strategy, culture, capabilities, talent, and ways of working.
  • Build physician safety leadership capability, coach Safety Medical personnel, and establish accountability for high-quality medical safety strategy and execution.
  • Translate portfolio safety strategy into clear priorities and deploy medical safety approaches consistently across programs in partnership with multidisciplinary teams.
  • Champion consistent, high-quality medical review, surveillance, signal management, benefit-risk assessment, and aggregate reporting.
  • Represent Neurocrine externally with regulatory authorities, collaborators, partners, and other stakeholders as appropriate.
  • Own people leadership, talent development, performance, and resource allocation for the physician safety team, aligning capabilities and capacity with pipeline needs.
  • Provide senior medical oversight of individual and aggregate safety data, including medical review, signal evaluation, and benefit-risk assessment.
  • Support or contribute to safety-related regulatory submissions and periodic reports, including DSURs, IND Annual Reports, PADERs, PBRERs, PSURs, and responses to regulatory inquiries.
  • Ensure scientific rigor, consistency, and quality of medical safety assessments across Neurocrine programs.

Desired Qualifications

  • Experience with ARISg is preferred.

About the Company

Neurocrine Biosciences

Develops and markets neurology-focused therapies

Neurocrine Biosciences develops and commercializes medicines for neurological and endocrine diseases. Its work centers on discovering and developing treatments, with INGREZZA (valbenazine) approved to treat adults with tardive dyskinesia and a pipeline of other drug candidates in various clinical stages. The company earns revenue from sales of approved medicines and from milestones and royalties from collaborations with partners. By focusing on both neurological and endocrine conditions, Neurocrine targets patients and healthcare professionals seeking therapies for conditions such as tardive dyskinesia, Parkinson's disease, and endometriosis. Its main goal is to bring therapies to market through development and commercialization, supported by ongoing research across its clinical programs to address unmet medical needs in these areas.

Company size
1,001-5,000
Company stage
IPO
Headquarters
San Diego, CA
Founded
1992

Recently Posted Jobs

Explore more opportunities at Neurocrine Biosciences

See more jobs